Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study

BACKGROUND: Bisphosphonate medications, including alendronate, ibandronate and risedronate administered orally and zoledronate, administered intravenously, are commonly prescribed for the treatment of osteoporosis based on evidence that, correctly taken, bisphosphonates can improve bone strength and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishop, Simon, Narayanasamy, Melanie Jay, Paskins, Zoe, Corp, Nadia, Bastounis, Anastasios, Griffin, Jill, Gittoes, Neil, Leonardi-Bee, Jo, Langley, Tessa, Sahota, Opinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540377/
https://www.ncbi.nlm.nih.gov/pubmed/37770860
http://dx.doi.org/10.1186/s12891-023-06865-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540377/
https://www.ncbi.nlm.nih.gov/pubmed/37770860
http://dx.doi.org/10.1186/s12891-023-06865-1

Ejemplares similares